Skip to main content

Table 1 Patient's characteristics

From: Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial

Pt. #

Age

/sex

Stage

/Grade

Diagnosis

Metastasis

R-M-1

62/M

TxNxM1(IV)

Clear cell RCC

Lung, Rib

R-G-2

56/M

T3bN1M1(IV)

Clear cell RCC

Lung, Paratracheal LN

R-K-3

67/M

T2N0M1(IV)

Clear cell RCC

Lung, Brain, Contralateral Kidney,

R-H-4

29/M

TxN2M0(II)

RCC

Local Recurrence

R-N-5

24/F

T2N2M1(IV)

Papillary RCC

Lung, Lower Neck, Supraclavicular & Retroperitoneal LN, Local Recurrence

R-L-6

62/M

TxNxM1(IV)

RCC

Thorax, Lung, Mediastinum

B-S-1

43/F

IV

Lt.breast cancer

Breast, Lung

B-H-2

29/F

IV

Bilateral breast cancer

Breast, Lung, skin, pleural

B-L-3

59/F

IIIC

Brest cancer

LN, chest wall, bone meta

B-Y-4

66/F

IIB

Rt.breast cancer

Bone, pleural liver